AstraZeneca Follows Pfizer In Seeking India Emergency Use Approval For COVID-19 Vaccine
AstraZeneca Plc’s (NASDAQ: AZN) partner, the Serum Institute of India, applied for emergency use authorization of the former's COVID-19 vaccine candidate on Sunday, as per
